Tencent-backed US drug discovery firm Atomwise closes $123m Series B round

Tencent-backed US drug discovery firm Atomwise closes $123m Series B round

12 August, 2020

Atomwise B Capital Group Baidu Ventures drug discovery Sanabil Investments Tencent

Printed by Unregistered user on Tue, 29 Jul 2025 05:11:48 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

B Capital leads funding in AI firm Atomwise, fishing app Fishbrain

Venture Capital

B Capital closes second global fund at $820m for B2B growth-stage investments

Read more from World

China’s FountainVest to buy major stake in Italy’s EuroGroup Laminations

Climate Tech & ESG

Brazil in talks with TPG, Brookfield to raise $4b for climate finance